Keyphrases
Intermediate Risk
100%
Atherosclerotic Disease
100%
United States Population
100%
Pooled Cohort Equations
100%
Risk Estimation
50%
10-year Risk
50%
Risk Factors
25%
Non-high-density Lipoprotein Cholesterol (non-HDL-C)
25%
Lipid-lowering Medications
25%
Low-density Lipoprotein Cholesterol (LDL-C)
25%
Statin Therapy
25%
Multiple Risk Factors
25%
Atherogenic Lipoproteins
25%
Apolipoprotein B (Apo B)
25%
Cholesterol Guidelines
25%
Risk Assessment
25%
US Adults
25%
NHANES
25%
Atherosclerotic Cardiovascular Disease (ASCVD)
25%
Patient Engagement
25%
Statin Eligibility
25%
Risk-enhancing Factors
25%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Biological Marker
100%
Prevalence
100%
Statin (Protein)
66%
Lipoprotein
33%
Coronary Artery Atherosclerosis
33%
Biochemistry, Genetics and Molecular Biology
Prevalence
100%
Statin
100%
Enhancer Region
50%
Lipid
50%
Lipoprotein
50%
Agricultural and Biological Sciences
Prevalence
100%
Risk Estimate
100%
Risk Factor
50%
Lipoprotein
50%
Cardiovascular System
50%
Immunology and Microbiology
Prevalence
100%
Enhancer Region
100%